TD SYNNEX CORP Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TD SYNNEX Corporation on January 25, 2023. The filing details a secondary public offering of common stock by certain entities managed by affiliates of Apollo Global Management, Inc. (the "Selling Stockholders").
Key Financial Metrics and Transaction Details
- Offering Size: 4,500,000 shares of Common Stock.
- Offering Price: $97.00 per share.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional 675,000 shares.
- Proceeds: The Company will not receive any proceeds from the sale of shares by the Selling Stockholders.
- Concurrent Share Repurchase: The Company agreed to purchase 900,000 shares from the Selling Stockholders at the offering price ($97.00 per share).
- Repurchase Funding: Funded using existing cash on hand under the Company's existing $1 billion share repurchase program.
- Underwriting Discount: No underwriting discount will be paid for the shares repurchased by the Company.
Note: This filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the Company's operations.
Material Changes
The primary material event is the execution of the Underwriting Agreement for the secondary offering and the concurrent share repurchase. There are no reported changes to the Company's operational financial metrics in this document.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond standard underwriting agreement terms. The transaction was approved by the Audit Committee, comprised of independent and disinterested directors.
Key Facts for Investor Verification
- Verify the total number of shares sold by Selling Stockholders versus the 900,000 shares repurchased by the Company.
- Confirm the impact of the $87.3 million repurchase (900,000 shares x $97.00) on the Company's cash balance.
- Review the full Underwriting Agreement (Exhibit 1.1) for lock-up provisions or other restrictions on the Selling Stockholders.
- Check subsequent filings to determine if the 30-day over-allotment option was exercised.